Kodiak Sciences (KOD) Long-Term Investments (2019 - 2020)
Kodiak Sciences (KOD) posted Long-Term Investments of $8.5 million for Q1 2020, down 27.04% on a QoQ basis from $11.7 million in Q4 2019.
Kodiak Sciences (KOD) Long-Term Investments (2019 - 2020) Analysis & Trends
Kodiak Sciences' Long-Term Investments history runs 2 years deep, the most recent figure standing at $8.5 million for Q1 2020.
- Quarterly Long-Term Investments changed N/A year-over-year to $8.5 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $8.5 million (changed N/A YoY) and the FY2019 annual result came in at $11.7 million, changed N/A from the prior year.
- Long-Term Investments was $8.5 million for Q1 2020 at Kodiak Sciences, down from $11.7 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $11.7 million in Q4 2019 and bottomed at $8.5 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 8.53 Mn |
| Dec 31, 2019 | 11.70 Mn |